Literature DB >> 20110377

Distinguishing recurrent primary brain tumor from radiation injury: a preliminary study using a susceptibility-weighted MR imaging-guided apparent diffusion coefficient analysis strategy.

A Al Sayyari1, R Buckley, C McHenery, K Pannek, A Coulthard, S Rose.   

Abstract

BACKGROUND AND
PURPOSE: The accurate delineation of tumor recurrence presents a significant problem in neuro-oncology. Our aim was to improve the identification of brain tumor recurrence from chemoradiation injury by using CE-SWI, a technique that provides improved visualization of the heterogeneous patterns of brain tumor pathology, to guide the analysis of ADC measures within the peritumoral territory.
MATERIALS AND METHODS: Seventeen patients who were being treated for high-grade glial neoplasms took part in the study. All patients presented with new enhancing lesions on follow-up CE-T1. Recurrence or chemoradiation injury was confirmed from either histologic analysis or extensive clinical follow-up. Regions of enhancement on registered CE-SWI and CE-T1 images were extracted in a semiautomated fashion and transferred to co-registered ADC maps. Significant differences in ADC measures defined within the enhancement volumes on serial MR images were analyzed by using a nonparametric Kolmogorov-Smirnov approach and correlated with clinical follow-up diagnoses.
RESULTS: Analysis of the serial data revealed that patients with a diagnosis of tumor recurrence had significantly reduced ADC measures within the enhancement volume delineated on CE-SWI. In contrast, patients with SD had significantly elevated ADC within the CE-SWI enhancement volume.
CONCLUSIONS: The findings of an increase in enhancement volume delineated on serial CE-SWI maps, along with a concomitant reduction in ADC within this volume for patients with recurrent tumor, provide support for such an approach to be used to assist in follow-up patient management strategies.

Entities:  

Mesh:

Year:  2010        PMID: 20110377      PMCID: PMC7963916          DOI: 10.3174/ajnr.A2011

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  17 in total

1.  A global optimisation method for robust affine registration of brain images.

Authors:  M Jenkinson; S Smith
Journal:  Med Image Anal       Date:  2001-06       Impact factor: 8.545

2.  High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings.

Authors:  K Pinker; I M Noebauer-Huhmann; I Stavrou; R Hoeftberger; P Szomolanyi; G Karanikas; M Weber; A Stadlbauer; E Knosp; K Friedrich; S Trattnig
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

3.  The role of diffusion-weighted imaging in patients with brain tumors.

Authors:  K Kono; Y Inoue; K Nakayama; M Shakudo; M Morino; K Ohata; K Wakasa; R Yamada
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

4.  Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence.

Authors:  Chiaki Asao; Yukunori Korogi; Mika Kitajima; Toshinori Hirai; Yuji Baba; Keishi Makino; Masato Kochi; Shoji Morishita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

5.  High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors.

Authors:  K Pinker; I M Noebauer-Huhmann; I Stavrou; R Hoeftberger; P Szomolanyi; M Weber; A Stadlbauer; G Grabner; E Knosp; S Trattnig
Journal:  Neuroradiology       Date:  2007-09-18       Impact factor: 2.804

Review 6.  Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Authors:  Dieta Brandsma; Lukas Stalpers; Walter Taal; Peter Sminia; Martin J van den Bent
Journal:  Lancet Oncol       Date:  2008-05       Impact factor: 41.316

7.  Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies.

Authors:  N Sadeghi; N D'Haene; C Decaestecker; M Levivier; T Metens; C Maris; D Wikler; D Baleriaux; I Salmon; S Goldman
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-13       Impact factor: 3.825

8.  Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics.

Authors:  Alexander C Guo; Thomas J Cummings; Rajesh C Dash; James M Provenzale
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

Review 9.  Susceptibility-weighted imaging: technical aspects and clinical applications, part 2.

Authors:  S Mittal; Z Wu; J Neelavalli; E M Haacke
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-08       Impact factor: 3.825

Review 10.  Fast robust automated brain extraction.

Authors:  Stephen M Smith
Journal:  Hum Brain Mapp       Date:  2002-11       Impact factor: 5.038

View more
  19 in total

Review 1.  Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.

Authors:  James R Fink; Mark Muzi; Melinda Peck; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2015-08-20       Impact factor: 10.057

2.  Radiation-induced cranial neuropathy in patients with nasopharyngeal carcinoma. A follow-up study.

Authors:  X Rong; Y Tang; M Chen; K Lu; Y Peng
Journal:  Strahlenther Onkol       Date:  2012-03       Impact factor: 3.621

3.  Histogram analysis of intravoxel incoherent motion for differentiating recurrent tumor from treatment effect in patients with glioblastoma: initial clinical experience.

Authors:  H S Kim; C H Suh; N Kim; C-G Choi; S J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-22       Impact factor: 3.825

Review 4.  Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies.

Authors:  Nishant Verma; Matthew C Cowperthwaite; Mark G Burnett; Mia K Markey
Journal:  Neuro Oncol       Date:  2013-01-16       Impact factor: 12.300

5.  Benefits of contrast-enhanced SWI in patients with glioblastoma multiforme.

Authors:  Delia Fahrendorf; Wolfram Schwindt; Johannes Wölfer; Astrid Jeibmann; Hendrik Kooijman; Harald Kugel; Oliver Grauer; Walter Heindel; Volker Hesselmann; Andrea Bink
Journal:  Eur Radiol       Date:  2013-08-01       Impact factor: 5.315

6.  Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.

Authors:  Morad Nasseri; Seymur Gahramanov; Joao Prola Netto; Rongwei Fu; Leslie L Muldoon; Csanad Varallyay; Bronwyn E Hamilton; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2014-02-11       Impact factor: 12.300

7.  Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters.

Authors:  Yae Won Park; Sung Soo Ahn; Eui Hyun Kim; Seok-Gu Kang; Jong Hee Chang; Se Hoon Kim; Jinyuan Zhou; Seung-Koo Lee
Journal:  Neuroradiology       Date:  2020-09-02       Impact factor: 2.804

Review 8.  Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade glioma.

Authors:  Janine M Lupo; Sarah J Nelson
Journal:  Semin Radiat Oncol       Date:  2014-07-26       Impact factor: 5.934

9.  Mean apparent diffusion coefficient values in defining radiotherapy planning target volumes in glioblastoma.

Authors:  Daniel Jeong; Christian Malalis; John A Arrington; Aaron S Field; Jung W Choi; Mehmet Kocak
Journal:  Quant Imaging Med Surg       Date:  2015-12

10.  Utility of intravoxel incoherent motion MR imaging for distinguishing recurrent metastatic tumor from treatment effect following gamma knife radiosurgery: initial experience.

Authors:  D Y Kim; H S Kim; M J Goh; C G Choi; S J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-26       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.